http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102278011-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15bd2ceab525a2485a2804eaedc2c335
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-20128
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-20132
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-20084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-20104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-30016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-20081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2576-026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T2207-10096
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7267
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F18-241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-5608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-055
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4082
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H30-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7246
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T3-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06T7-174
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7264
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F18-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01R33-4806
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4848
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H30-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06T7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01R33-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-055
filingDate 2021-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e4758ee77c0e86511a2822908351836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9e7fcc8b7c6633ac127c8fb89fe3847
publicationDate 2021-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102278011-B1
titleOfInvention device and method to increase the probability of clinical trial success by selecting a group of patients with Parkinson's using neuromelanine image
abstract an apparatus for providing information about Parkinson's disease including an image receiving unit, an image preprocessing unit, an image processing unit, and an image analyzing unit; and a server communicating with the central management unit and/or the Parkinson's disease information providing device; in the system for increasing the clinical trial success probability by selecting a patient group with Parkinson's disease, the image receiving unit, An MRI image obtained by photographing the brains of a plurality of patients who are candidates for clinical trials is obtained, and the image preprocessor pre-processes the obtained MRI image so that the neuromelanin region used as an image biomarker for Parkinson's disease can be observed , The image processing unit analyzes the pre-processed MRI image to classify a first image including the neuromelanin region, detects the neuromelanin region from the classified first image, and the image analyzer includes the detection The central management unit determines information on the patient related to Parkinson's disease by analyzing the neuromelanin region, and provides information on at least one first patient that satisfies the first condition among the plurality of patients based on the patient information. and/or transmitted to the server, wherein the central management unit and/or the server may use the clinical trial results for the first patient to prove the drug efficacy.
priorityDate 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015125057-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5814
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407182981
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544741

Total number of triples: 52.